All forward-looking statements, including without limitation, those relating to our operating trends and future financial performance, the impact of COVID-19 on our business and prospects for recovery, expense management, Expectations for hiring, growth in our organization, market opportunity, guidance for revenue, gross margin and operating expenses, commercial expansion, and product pipeline development, expected future product launches and milestones, and expected results and performance of our partnership and commercial products, including patient outcomes, are based upon our current estimates and various assumptions.

Mar 3, 2022 / receipt, needs a key / Ron Lloyd, CEO | earnings call 2022-03-03 | transcript 65bc019d-478d-4dd4-b00a-8597fb0704d5 | chars 1385-2014 | segment 1